Larvol Delta - BladderSparing-Treatment-With-Disitamab-Vedotin-and-Toripalimab-With-or-Without-Pelvic-Lymph-Node-Dissection-in-Bladder-Cancer

Aidixi (disitamab vedotin) - Pfizer, RemeGen

Loqtorzi (toripalimab-tpzi) - Shanghai Junshi Bioscience, Coherus Oncology

http://clinicaltrials.gov/ct2/show/NCT07756008

Aug 11, 2026

SHARE THIS

Print
Email
More sharing

Reddit

StumbleUpon

Delicious

Prev Next